VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

40 hedge funds and large institutions have $9.58M invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
40
Holders Change
-2
Holders Change %
-4.76%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
8
Reduced
7
Closed
6
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
+$5K
Name Market Value Shares Shares
Change
Shares
Change %
PCMC
26
Planning Capital Management Corporation
Pennsylvania
$7.42K 7,272
Simplex Trading
27
Simplex Trading
Illinois
$4K 4,884 +4,884 New
RM
28
RP Management
New York
$3.77K 3,700
IWP
29
IAG Wealth Partners
Wisconsin
$3.06K 3,000
Barclays
30
Barclays
United Kingdom
$3K 2,668
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$2K 2,068 -8,437 -80%
NS
32
NBC Securities
Alabama
$1K 1,400 +1,400 New
JPMorgan Chase & Co
33
JPMorgan Chase & Co
New York
$735 721
Wells Fargo
34
Wells Fargo
California
$392 385 +3 +0.8%
ITIM
35
Indiana Trust & Investment Management
Indiana
$204 200
UBS Group
36
UBS Group
Switzerland
$97 95 -168,573 -100%
NA
37
NewEdge Advisors
Louisiana
$14 14
PA
38
Parallel Advisors
California
$8 8
AA
39
Addison Advisors
Vermont
$5 4
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$2 2
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
-41,412 Closed
Squarepoint
42
Squarepoint
New York
-36,098 Closed
VF
43
Virtu Financial
New York
-27,378 Closed
TSS
44
Two Sigma Securities
New York
-15,634 Closed
BCM
45
Bourgeon Capital Management
Connecticut
-7,500 Closed
PO
46
Private Ocean
California
-3 Closed
CFGS
47
Concourse Financial Group Securities
Alabama